Boston Trust Walden’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$382K Hold
5,471
﹤0.01% 334
2025
Q1
$402K Hold
5,471
﹤0.01% 325
2024
Q4
$358K Sell
5,471
-695
-11% -$45.5K ﹤0.01% 339
2024
Q3
$480K Buy
6,166
+711
+13% +$55.4K ﹤0.01% 320
2024
Q2
$425K Buy
5,455
+55
+1% +$4.29K ﹤0.01% 328
2024
Q1
$366K Hold
5,400
﹤0.01% 335
2023
Q4
$364K Hold
5,400
﹤0.01% 330
2023
Q3
$366K Hold
5,400
﹤0.01% 319
2023
Q2
$386K Hold
5,400
﹤0.01% 322
2023
Q1
$375K Hold
5,400
﹤0.01% 325
2022
Q4
$366K Hold
5,400
﹤0.01% 326
2022
Q3
$296K Hold
5,400
﹤0.01% 327
2022
Q2
$357K Hold
5,400
﹤0.01% 326
2022
Q1
$358K Hold
5,400
﹤0.01% 335
2021
Q4
$315K Hold
5,400
﹤0.01% 356
2021
Q3
$324K Hold
5,400
﹤0.01% 347
2021
Q2
$323K Hold
5,400
﹤0.01% 351
2021
Q1
$268K Hold
5,400
﹤0.01% 350
2020
Q4
$270K Hold
5,400
﹤0.01% 353
2020
Q3
$296K Hold
5,400
﹤0.01% 340
2020
Q2
$286K Hold
5,400
﹤0.01% 338
2020
Q1
$241K Hold
5,400
﹤0.01% 334
2019
Q4
$269K Hold
5,400
﹤0.01% 356
2019
Q3
$241K Hold
5,400
﹤0.01% 363
2019
Q2
$223K Hold
5,400
﹤0.01% 368
2019
Q1
$218K Hold
5,400
﹤0.01% 370
2018
Q4
$205K Hold
5,400
﹤0.01% 367
2018
Q3
$214K Buy
+5,400
New +$214K ﹤0.01% 372
2014
Q3
Sell
-5,400
Closed -$201K 336
2014
Q2
$201K Buy
+5,400
New +$201K ﹤0.01% 335